Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
Next
(134)
•••
Hotspurs
X
View Profile
View Bullboard History
Post by
Hotspurs
on Jan 17, 2021 6:39pm
Pre clinical haves started see Talems pipeline
Pipeline
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 17, 2021 6:22pm
Accumulation by Smart Money
When I look at 72 Credit Suise and 39 Merrill Lynch with high average purchase prices compared to CIBC the manipulator here, I feel assured I have picked a winner. Can't predict when,
...more
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 17, 2021 6:20pm
Broker Summary
House Positions for C:IPA from 20201216 to 20210115 House Bought $Val Ave Sold $Val Ave Net $Net
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Jan 13, 2021 6:49am
RE:Door is wide open for a efficacious therapeutic
Tell us something we don't already know. The trials which were due to start in January and take 4 weeks to complete. Have they begun and if so when? Several companies have already completed
...more
(134)
•••
Hotspurs
X
View Profile
View Bullboard History
Post by
Hotspurs
on Jan 11, 2021 11:09pm
Door is wide open for a efficacious therapeutic
https://theprovince.com/news/u-s-pharmaceutical-giant-lashes-out-b-c-ministry-of-health-after-drug-rejection/wcm/c77295f1-1a8f-4a82-93f2-6c72ce4df9f5/amp/#click=https://t.co/18EssT8Fe3
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 11, 2021 7:54pm
New Investor Deck Jan 11
Same slides as jpm, stern ir, hc wainwright presentation - NEW INVESTOR DECK JAN 11 https://www.immunoprecise.com/wp-content/uploads/2021/01/IPA_Investor_Deck_Janu2021.pdf
(80)
•••
bingostar
X
View Profile
View Bullboard History
Comment by
bingostar
on Jan 06, 2021 8:54am
RE:RE:Cruising through after hours nicely
IPA is well postionned to tackle variants of the covid with its antibody cocktail, it will pay long term.
(2)
•••
theNorm
X
View Profile
View Bullboard History
Comment by
theNorm
on Jan 05, 2021 8:39pm
RE:Cruising through after hours nicely
Check out CEO.ca tonight. Some real good discussion and dd, imo. Here is the final after hrs tally Time ET Ex Price Change Volume
...more
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 05, 2021 6:27pm
Cruising through after hours nicely
Recent Trades - Last 10 of 771 Time ET Ex Price Change Volume 17:56:01 Q 17.00 3.60 113
...more
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 05, 2021 4:57am
JP Morgan Conference
https://sternir.com/JPM-2021 JP MORGAN is holding a virtual conference Jan 11-14 IPA is being promoted and we could see the shelf short form prospectus their holding brought into play. It allows for
...more
(1)
•••
Right80%
X
View Profile
View Bullboard History
Post by
Right80%
on Jan 04, 2021 10:10am
Very underwhelming
Clearly it got way ahead of itself. What's the floor $15 CAD? Nobody seems to care.
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 03, 2021 3:45am
Evening folks
Sentiment remains positive on CEO.ca and Yahoo This will be one hellacious week to get through until the vote in the US Senate, as theDonald spreads fear in his last hours of power. The
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 01, 2021 9:27pm
Happy new year Do your Own DD
https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
(2)
•••
theNorm
X
View Profile
View Bullboard History
Post by
theNorm
on Jan 01, 2021 6:21pm
Dec 30th news of New Consortium
IPA has vast amounts of expertise, patented IP and the most sought after antibodies and antigens They are becoming the dominate player in this space. With this latest collaboration they have
...more
Prev
...
21
22
23
24
25
26
27
28
29
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing